Citigroup
OYST

Citigroup’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Citigroup’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,878
Closed -$211K – 6093
2022
Q4 		$211K Buy
18,878
+18,564
+5,912% +$180K ﹤0.01% 3692
2022
Q3 		$2K Sell
314
-198
-39% -$1.24K ﹤0.01% 5583
2022
Q2 		$2K Sell
512
-531
-51% -$3.02K ﹤0.01% 5959
2022
Q1 		$12K Sell
1,043
-87,830
-99% -$1.05M ﹤0.01% 5464
2021
Q4 		$1.62M Buy
88,873
+87,603
+6,898% +$1.11M ﹤0.01% 2794
2021
Q3 		$15K Buy
1,270
+740
+140% +$10.8K ﹤0.01% 5366
2021
Q2 		$9K Buy
530
+128
+32% +$2.43K ﹤0.01% 5721
2021
Q1 		$7K Sell
402
-1,321
-77% -$27.7K ﹤0.01% 5830
2020
Q4 		$32K Buy
1,723
+813
+89% +$17.5K ﹤0.01% 6355
2020
Q3 		$20K Sell
910
-460
-34% -$10.8K ﹤0.01% 6213
2020
Q2 		$40K Sell
1,370
-278
-17% -$8.38K ﹤0.01% 6163
2020
Q1 		$58K Buy
1,648
+519
+46% +$16.8K ﹤0.01% 5854
2019
Q4 		$28K Buy
+1,129
New +$19.8K ﹤0.01% 6761

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's OYST Position: Q1 2023 in Review

Citigroup sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 18,878 shares — an estimated $211K sold.

Citigroup first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $1.62M in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Citigroup reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 18,878 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $211K.
  • Citigroup first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • Citigroup's Oyster Point Pharma, Inc. Common Stock position peaked at $1.62M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.